Allotera Therapeutics
Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies
$35MSeries C
Role not disclosedBo
Banc of California
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $245M 2 disclosed · full round size, not this investor’s share